The immunomodulatory role of all-trans retinoic acid in tumor microenvironment

[1]  Li-Na Wei,et al.  CRABP1 in Non-Canonical Activities of Retinoic Acid in Health and Diseases , 2022, Nutrients.

[2]  M. Pittet,et al.  Clinical relevance of tumour-associated macrophages , 2022, Nature Reviews Clinical Oncology.

[3]  M. Millward,et al.  Retinoic Acid Induces an IFN-Driven Inflammatory Tumour Microenvironment, Sensitizing to Immune Checkpoint Therapy , 2022, Frontiers in Oncology.

[4]  C. Arienti,et al.  Emerging Roles of Aldehyde Dehydrogenase Isoforms in Anti-cancer Therapy Resistance , 2022, Frontiers in Medicine.

[5]  S. Macip,et al.  A master of all trades – linking retinoids to different signalling pathways through the multi-purpose receptor STRA6 , 2021, Cell death discovery.

[6]  D. Gabrilovich,et al.  Myeloid-Derived Suppressor Cells: A Propitious Road to Clinic. , 2021, Cancer discovery.

[7]  Dan Li,et al.  Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer , 2021, Signal Transduction and Targeted Therapy.

[8]  R. Weichselbaum,et al.  All-trans retinoic acid overcomes solid tumor radioresistance by inducing inflammatory macrophages , 2021, Science Immunology.

[9]  S. Hasegawa,et al.  Vitamin A in health care: Suppression of growth and induction of differentiation in cancer cells by vitamin A and its derivatives and their mechanisms of action. , 2021, Pharmacology & therapeutics.

[10]  A. Scialdone,et al.  Retinoic acid signaling is critical during the totipotency window in early mammalian development , 2021, Nature Structural & Molecular Biology.

[11]  Jie Xie,et al.  All-trans-retinoic acid restores CD4+ T cell response after sepsis by inhibiting the expansion and activation of myeloid-derived suppressor cells. , 2021, Molecular immunology.

[12]  Qianqian Zhao,et al.  Overview of all-trans-retinoic acid (ATRA) and its analogues: Structures, activities, and mechanisms in acute promyelocytic leukaemia. , 2021, European journal of medicinal chemistry.

[13]  L. Tran,et al.  Inhibition of Granulocytic Myeloid-Derived Suppressor Cells Overcomes Resistance to Immune Checkpoint Inhibition in LKB1-Deficient Non–Small Cell Lung Cancer , 2021, Cancer Research.

[14]  G. Walzl,et al.  Targeting of myeloid-derived suppressor cells by all-trans retinoic acid as host-directed therapy for human tuberculosis , 2021, Cellular immunology.

[15]  H. Kantarjian,et al.  Acute myeloid leukemia: Treatment and research outlook for 2021 and the MD Anderson approach , 2021, Cancer.

[16]  H. de Thé,et al.  Retinoids in haematology : a timely revival? , 2021, Blood.

[17]  D. Gabrilovich,et al.  Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity , 2021, Nature Reviews Immunology.

[18]  C. Porte,et al.  Dysregulation of lipid metabolism in PLHC-1 and ZFL cells exposed to tributyltin an all-trans retinoic acid. , 2020, Aquatic toxicology.

[19]  Hong-Wei Sun,et al.  Retinoic Acid Synthesis Deficiency Fosters the Generation of Polymorphonuclear Myeloid-Derived Suppressor Cells in Colorectal Cancer , 2020, Cancer Immunology Research.

[20]  T. Enver,et al.  Advances and challenges in retinoid delivery systems in regenerative and therapeutic medicine , 2020, Nature Communications.

[21]  W. Lei,et al.  Retinoic acid promotes metabolic maturation of human Embryonic Stem Cell-derived Cardiomyocytes , 2020, Theranostics.

[22]  Zheng Yong,et al.  ST1926 inhibits glioma progression through regulating mitochondrial complex II. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[23]  A. Ross,et al.  Our Current Dietary Reference Intakes for Vitamin A—Now 20 Years Old , 2020, Current developments in nutrition.

[24]  I. Asangani,et al.  Tumor-Derived Retinoic Acid Regulates Intratumoral Monocyte Differentiation to Promote Immune Suppression , 2020, Cell.

[25]  K. Leandersson,et al.  The Generation and Identity of Human Myeloid-Derived Suppressor Cells , 2020, Frontiers in Oncology.

[26]  J. Xu,et al.  Increased levels of myeloid-derived suppressor cells in esophageal cancer patients is associated with the complication of sepsis. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[27]  A. Mantovani,et al.  Diversity, Mechanisms, and Significance of Macrophage Plasticity. , 2020, Annual review of pathology.

[28]  H. Fan,et al.  STRA6 exerts oncogenic role in gastric tumorigenesis by acting as a crucial target of miR-873 , 2019, Journal of Experimental & Clinical Cancer Research.

[29]  I. Melero,et al.  Dendritic cells in cancer immunology and immunotherapy , 2019, Nature Reviews Immunology.

[30]  Qiaojun He,et al.  Inhibition of M2-like macrophages by all-trans retinoic acid prevents cancer initiation and stemness in osteosarcoma cells , 2019, Acta Pharmacologica Sinica.

[31]  P. Loke,et al.  Specialized dendritic cells induce tumor-promoting IL-10+IL-17+ FoxP3neg regulatory CD4+ T cells in pancreatic carcinoma , 2019, Nature Communications.

[32]  H. Nishikawa,et al.  Regulatory T cells in cancer immunosuppression — implications for anticancer therapy , 2019, Nature Reviews Clinical Oncology.

[33]  Xiaoling Ni,et al.  The success and the challenge of all-trans retinoic acid in the treatment of cancer , 2018, Critical reviews in food science and nutrition.

[34]  Kimberly R. Jordan,et al.  Targeting myeloid‐derived suppressor cells using all‐trans retinoic acid in melanoma patients treated with Ipilimumab , 2018, International immunopharmacology.

[35]  A. Rolfe,et al.  Genetic screen in myeloid cells identifies TNF-α autocrine secretion as a factor increasing MDSC suppressive activity via Nos2 up-regulation , 2018, Scientific Reports.

[36]  E. Dmitrovsky,et al.  CD38-Mediated Immunosuppression as a Mechanism of Tumor Cell Escape from PD-1/PD-L1 Blockade. , 2018, Cancer discovery.

[37]  Ning Wang,et al.  Inhibition of cancer stem cell like cells by a synthetic retinoid , 2018, Nature Communications.

[38]  Matthew Collin,et al.  Human dendritic cell subsets: an update , 2018, Immunology.

[39]  F. Venet,et al.  Advances in the understanding and treatment of sepsis-induced immunosuppression , 2018, Nature Reviews Nephrology.

[40]  P. Ji,et al.  Age-related inflammatory bone marrow microenvironment induces ineffective erythropoiesis mimicking del(5q) MDS , 2017, Leukemia.

[41]  R. He,et al.  Topical treatment of all‐trans retinoic acid inhibits murine melanoma partly by promoting CD8+ T‐cell immunity , 2017, Immunology.

[42]  H. Gevensleben,et al.  Targeting myeloid derived suppressor cells with all-trans retinoic acid is highly time-dependent in therapeutic tumor vaccination , 2017, Oncoimmunology.

[43]  M. Kalady,et al.  RBP4-STRA6 Pathway Drives Cancer Stem Cell Maintenance and Mediates High-Fat Diet-Induced Colon Carcinogenesis , 2017, Stem cell reports.

[44]  G. Fernández,et al.  Novel Use of All-Trans-Retinoic Acid in A Model of Lipopolysaccharide-Immunosuppression to Decrease the Generation of Myeloid-Derived Suppressor Cells by Reducing the Proliferation of CD34+ Precursor Cells , 2017, Shock.

[45]  Qiaojun He,et al.  All-Trans Retinoic Acid Prevents Osteosarcoma Metastasis by Inhibiting M2 Polarization of Tumor-Associated Macrophages , 2017, Cancer Immunology Research.

[46]  M. Zöller,et al.  Efficacy of vaccination with tumor-exosome loaded dendritic cells combined with cytotoxic drug treatment in pancreatic cancer , 2017, Oncoimmunology.

[47]  R. Mebius,et al.  Retinoic Acid and Immune Homeostasis: A Balancing Act. , 2017, Trends in immunology.

[48]  M. Philip,et al.  CD8+ T cell differentiation and dysfunction in cancer , 2016, Nature Reviews Immunology.

[49]  A. S. Green,et al.  Meeting the Vitamin A Requirement: The Efficacy and Importance of β-Carotene in Animal Species , 2016, TheScientificWorldJournal.

[50]  N. Bhattacharya,et al.  Normalizing Microbiota-Induced Retinoic Acid Deficiency Stimulates Protective CD8(+) T Cell-Mediated Immunity in Colorectal Cancer. , 2016, Immunity.

[51]  R. Orentas,et al.  Reduction of MDSCs with All-trans Retinoic Acid Improves CAR Therapy Efficacy for Sarcomas , 2016, Cancer Immunology Research.

[52]  Peter J. Murray,et al.  Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards , 2016, Nature Communications.

[53]  J. Welch,et al.  Pathways of retinoid synthesis in mouse macrophages and bone marrow cells , 2016, Journal of leukocyte biology.

[54]  M. A. K. Widjaja-Adhi,et al.  Transport of vitamin A across blood‐tissue barriers is facilitated by STRA6 , 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[55]  D. Gabrilovich,et al.  The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment. , 2016, Trends in immunology.

[56]  D. Gabrilovich,et al.  Transcriptional regulation of myeloid‐derived suppressor cells , 2015, Journal of leukocyte biology.

[57]  Mladen Korbelik,et al.  Immunoregulatory Cell Depletion Improves the Efficacy of Photodynamic Therapy-Generated Cancer Vaccines , 2015, International journal of molecular sciences.

[58]  R. Kawaguchi,et al.  Vitamin A Transport Mechanism of the Multitransmembrane Cell-Surface Receptor STRA6 , 2015, Membranes.

[59]  Yong-He Hu,et al.  ALDH1 Expression and the Prognosis of Lung Cancer: A Systematic Review and Meta-Analysis. , 2015, Heart, lung & circulation.

[60]  L. Boon,et al.  Network analysis of immunotherapy-induced regressing tumours identifies novel synergistic drug combinations , 2015, Scientific Reports.

[61]  T. Ratliff,et al.  Expression of Cationic Amino Acid Transporter 2 Is Required for Myeloid-Derived Suppressor Cell–Mediated Control of T Cell Immunity , 2015, The Journal of Immunology.

[62]  G. Duester,et al.  Mechanisms of retinoic acid signalling and its roles in organ and limb development , 2015, Nature Reviews Molecular Cell Biology.

[63]  J. Mackey,et al.  Aldehyde dehydrogenase 1A3 influences breast cancer progression via differential retinoic acid signaling , 2015, Molecular oncology.

[64]  V. Křen,et al.  Pharmacogenomic analysis of retinoic-acid induced dyslipidemia in congenic rat model , 2014, Lipids in Health and Disease.

[65]  J. Ablain,et al.  Retinoic acid signaling in cancer: The parable of acute promyelocytic leukemia , 2014, International journal of cancer.

[66]  N. Noy,et al.  Holo-retinol-binding protein and its receptor STRA6 drive oncogenic transformation. , 2014, Cancer research.

[67]  P. Pisa,et al.  All trans-retinoic acid abrogates the pro-tumorigenic phenotype of prostate cancer tumor-associated macrophages. , 2014, International immunopharmacology.

[68]  Xiang Fu,et al.  ALDH1A1 overexpression is associated with the progression and prognosis in gastric cancer , 2014, BMC Cancer.

[69]  D. Clemente,et al.  The synthetic retinoid Am80 delays recovery in a model of multiple sclerosis by modulating myeloid-derived suppressor cell fate and viability , 2014, Neurobiology of Disease.

[70]  M. Matho,et al.  Unique Lamina Propria Stromal Cells Imprint the Functional Phenotype of Mucosal Dendritic Cells , 2014, Mucosal Immunology.

[71]  R. Kiessling,et al.  Ipilimumab treatment results in an early decrease in the frequency of circulating granulocytic myeloid derived suppressor cells as well as their arginase1 production , 2014, Journal of Translational Medicine.

[72]  P. Dessen,et al.  PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation , 2014, The Journal of experimental medicine.

[73]  K. Mills,et al.  Modulation of T Cell and Innate Immune Responses by Retinoic Acid , 2014, The Journal of Immunology.

[74]  R. Evans,et al.  Nuclear Receptors, RXR, and the Big Bang , 2014, Cell.

[75]  F. Rastinejad,et al.  Retinoic acid actions through mammalian nuclear receptors. , 2014, Chemical reviews.

[76]  Sheng Wei,et al.  Induction of myelodysplasia by myeloid-derived suppressor cells. , 2013, The Journal of clinical investigation.

[77]  J. Gribben,et al.  Activated pancreatic stellate cells sequester CD8+ T cells to reduce their infiltration of the juxtatumoral compartment of pancreatic ductal adenocarcinoma. , 2013, Gastroenterology.

[78]  Guoxun Chen.  Roles of Vitamin A Metabolism in the Development of Hepatic Insulin Resistance , 2013, ISRN hepatology.

[79]  M. Mark,et al.  The STRA6 Receptor Is Essential for Retinol-binding Protein-induced Insulin Resistance but Not for Maintaining Vitamin A Homeostasis in Tissues Other Than the Eye* , 2013, The Journal of Biological Chemistry.

[80]  K. Else,et al.  The retinoic acid-producing capacity of gut dendritic cells and macrophages is reduced during persistent T. muris infection , 2013, Parasite immunology.

[81]  L. Dyck,et al.  Blocking retinoic acid receptor-α enhances the efficacy of a dendritic cell vaccine against tumours by suppressing the induction of regulatory T cells , 2013, Cancer Immunology, Immunotherapy.

[82]  Dung-Tsa Chen,et al.  Therapeutic regulation of myeloid-derived suppressor cells and immune response to cancer vaccine in patients with extensive stage small cell lung cancer , 2013, Cancer Immunology, Immunotherapy.

[83]  R. Noelle,et al.  Critical Role for All-trans Retinoic Acid for Optimal Effector and Effector Memory CD8 T Cell Differentiation , 2013, The Journal of Immunology.

[84]  Pratik Aryal,et al.  Liver Retinol Transporter and Receptor for Serum Retinol-binding Protein (RBP4)* , 2012, The Journal of Biological Chemistry.

[85]  E. Dmitrovsky,et al.  A retinoic acid--rich tumor microenvironment provides clonal survival cues for tumor-specific CD8(+) T cells. , 2012, Cancer research.

[86]  P. Chambon,et al.  Retinoic acid induces Sertoli cell paracrine signals for spermatogonia differentiation but cell autonomously drives spermatocyte meiosis , 2012, Proceedings of the National Academy of Sciences.

[87]  Hyun-Jeong Ko,et al.  The restoration of myeloid‐derived suppressor cells as functional antigen‐presenting cells by NKT cell help and all‐trans‐retinoic acid treatment , 2012, International journal of cancer.

[88]  L. Wheeler,et al.  Epithelial expression of the cytosolic retinoid chaperone cellular retinol binding protein II is essential for in vivo imprinting of local gut dendritic cells by lumenal retinoids. , 2012, The American journal of pathology.

[89]  T. Khoury,et al.  Aldehyde dehydrogenase 1A1 expression in breast cancer is associated with stage, triple negativity, and outcome to neoadjuvant chemotherapy , 2012, Modern Pathology.

[90]  U. Taschler,et al.  Retinyl ester hydrolases and their roles in vitamin A homeostasis , 2012, Biochimica et biophysica acta.

[91]  I. Biaggioni,et al.  Adenosinergic Regulation of the Expansion and Immunosuppressive Activity of CD11b+Gr1+ Cells , 2011, The Journal of Immunology.

[92]  W. Blaner,et al.  Vitamin A Metabolism: An Update , 2011, Nutrients.

[93]  Philippe Lefebvre,et al.  Retinoid X receptors: common heterodimerization partners with distinct functions , 2010, Trends in Endocrinology & Metabolism.

[94]  Si-young Song,et al.  Efficient Induction of CCR9 on T Cells Requires Coactivation of Retinoic Acid Receptors and Retinoid X Receptors (RXRs): Exaggerated T Cell Homing to the Intestine by RXR Activation with Organotins , 2010, The Journal of Immunology.

[95]  K. Hoag,et al.  Vitamin A upregulates matrix metalloproteinase-9 activity by murine myeloid dendritic cells through a nonclassical transcriptional mechanism. , 2010, The Journal of nutrition.

[96]  L. Gudas,et al.  Epigenetic Regulatory Mechanisms Distinguish Retinoic Acid-mediated Transcriptional Responses in Stem Cells and Fibroblasts* , 2010, The Journal of Biological Chemistry.

[97]  M. Pla,et al.  DNA vaccination with all-trans retinoic acid treatment induces long-term survival and elicits specific immune responses requiring CD4+ and CD8+ T-cell activation in an acute promyelocytic leukemia mouse model. , 2010, Blood.

[98]  Zhenqiu Liu,et al.  ALDH1A1 Is a Marker for Malignant Prostate Stem Cells and Predictor of Prostate Cancer Patients’ Outcome , 2009, Laboratory Investigation.

[99]  R. Albalat.  The retinoic acid machinery in invertebrates: Ancestral elements and vertebrate innovations , 2009, Molecular and Cellular Endocrinology.

[100]  K. Kretschmer,et al.  Retinoic acid can enhance conversion of naive into regulatory T cells independently of secreted cytokines , 2009, The Journal of experimental medicine.

[101]  T. Padhya,et al.  Mechanism Regulating Reactive Oxygen Species in Tumor-Induced Myeloid-Derived Suppressor Cells1 , 2009, The Journal of Immunology.

[102]  Feng Jiang,et al.  Aldehyde Dehydrogenase 1 Is a Tumor Stem Cell-Associated Marker in Lung Cancer , 2009, Molecular Cancer Research.

[103]  B. Pulendran,et al.  TLR2 dependent induction of vitamin A metabolizing enzymes in dendritic cells promotes T regulatory responses and inhibits TH-17 mediated autoimmunity , 2009, Nature Medicine.

[104]  P. Dahm,et al.  Reversal of Myeloid Cell–Mediated Immunosuppression in Patients with Metastatic Renal Cell Carcinoma , 2008, Clinical Cancer Research.

[105]  P. Chambon,et al.  Retinoic acid enhances Foxp3 induction indirectly by relieving inhibition from CD4+CD44hi Cells. , 2008, Immunity.

[106]  Hua Yu,et al.  Stat3 mediates myeloid cell-dependent tumor angiogenesis in mice. , 2008, The Journal of clinical investigation.

[107]  G. Duester.  Retinoic Acid Synthesis and Signaling during Early Organogenesis , 2008, Cell.

[108]  P. Rodriguez,et al.  Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives , 2008, Immunological reviews.

[109]  Zhen-yi Wang,et al.  Acute promyelocytic leukemia: from highly fatal to highly curable. , 2008, Blood.

[110]  M. Kane,et al.  Quantitative profiling of endogenous retinoic acid in vivo and in vitro by tandem mass spectrometry. , 2008, Analytical chemistry.

[111]  M. Fishman,et al.  Mechanism of all-trans retinoic acid effect on tumor-associated myeloid-derived suppressor cells. , 2007, Cancer research.

[112]  R. Shirkoohi,et al.  All-trans Retinoic Acid Enhances Murine Dendritic Cell Migration to Draining Lymph Nodes via the Balance of Matrix Metalloproteinases and Their Inhibitors1 , 2007, The Journal of Immunology.

[113]  H. Broxmeyer,et al.  Vitamin A Metabolites Induce Gut-Homing FoxP3+ Regulatory T Cells1 , 2007, The Journal of Immunology.

[114]  L. Gudas,et al.  Retinoid regulated association of transcriptional co-regulators and the polycomb group protein SUZ12 with the retinoic acid response elements of Hoxa1, RARbeta(2), and Cyp26A1 in F9 embryonal carcinoma cells. , 2007, Journal of molecular biology.

[115]  R. Noelle,et al.  All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation , 2007, The Journal of experimental medicine.

[116]  Y. Belkaid,et al.  A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-β– and retinoic acid–dependent mechanism , 2007, The Journal of experimental medicine.

[117]  Hilde Cheroutre,et al.  Reciprocal TH17 and Regulatory T Cell Differentiation Mediated by Retinoic Acid , 2007, Science.

[118]  P. Chambon,et al.  CYP26A1 and CYP26C1 cooperatively regulate anterior-posterior patterning of the developing brain and the production of migratory cranial neural crest cells in the mouse. , 2007, Developmental biology.

[119]  P. Ping,et al.  A Membrane Receptor for Retinol Binding Protein Mediates Cellular Uptake of Vitamin A , 2007, Science.

[120]  Ingo Fricke,et al.  All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients. , 2006, Cancer research.

[121]  R. Evans,et al.  Anatomical Profiling of Nuclear Receptor Expression Reveals a Hierarchical Transcriptional Network , 2006, Cell.

[122]  U. Eriksson,et al.  Understanding Retinol Metabolism: Structure and Function of Retinol Dehydrogenases* , 2006, Journal of Biological Chemistry.

[123]  Jonathan R Pollack,et al.  The retinoic acid synthesis gene ALDH1a2 is a candidate tumor suppressor in prostate cancer. , 2005, Cancer research.

[124]  P. Chambon,et al.  Contribution of cellular retinol‐binding protein type 1 to retinol metabolism during mouse development , 2005, Developmental dynamics : an official publication of the American Association of Anatomists.

[125]  A. Aranda,et al.  Rapid effects of retinoic acid on CREB and ERK phosphorylation in neuronal cells. , 2004, Molecular biology of the cell.

[126]  Si-young Song,et al.  Retinoic acid imprints gut-homing specificity on T cells. , 2004, Immunity.

[127]  B. Fingleton,et al.  Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis. , 2004, Cancer cell.

[128]  Y. Saijoh,et al.  Regulation of retinoic acid distribution is required for proximodistal patterning and outgrowth of the developing mouse limb. , 2004, Developmental cell.

[129]  D. Gabrilovich,et al.  Antigen-Specific Inhibition of CD8+ T Cell Response by Immature Myeloid Cells in Cancer Is Mediated by Reactive Oxygen Species1 , 2004, The Journal of Immunology.

[130]  S. Minucci,et al.  Retinoic Acid Receptor α Fusion to PML Affects Its Transcriptional and Chromatin-Remodeling Properties , 2003, Molecular and Cellular Biology.

[131]  A. Falanga,et al.  Pathogenesis and management of the bleeding diathesis in acute promyelocytic leukaemia. , 2003, Best practice & research. Clinical haematology.

[132]  D. Gabrilovich,et al.  Inhibition of myeloid cell differentiation in cancer: the role of reactive oxygen species , 2003, Journal of leukocyte biology.

[133]  Bin Yu,et al.  All-trans-retinoic acid eliminates immature myeloid cells from tumor-bearing mice and improves the effect of vaccination. , 2003, Cancer research.

[134]  G. Duester,et al.  Cytosolic retinoid dehydrogenases govern ubiquitous metabolism of retinol to retinaldehyde followed by tissue-specific metabolism to retinoic acid. , 2003, Chemico-biological interactions.

[135]  G. McArthur,et al.  Retinoic acid receptor antagonism in vivo expands the numbers of precursor cells during granulopoiesis , 2002, Leukemia.

[136]  R. Hasina,et al.  Retinoic acid modulates the ability of macrophages to participate in the induction of the angiogenic phenotype in head and neck squamous cell carcinoma , 2002, International journal of cancer.

[137]  C. Dani,et al.  Retinoic acid activation of the ERK pathway is required for embryonic stem cell commitment into the adipocyte lineage. , 2002, The Biochemical journal.

[138]  A. Visintin,et al.  Myeloid Suppressor Lines Inhibit T Cell Responses by an NO-Dependent Mechanism1 , 2002, The Journal of Immunology.

[139]  T. Pham,et al.  Overexpression of the retinoic acid-responsive gene Stra6 in human cancers and its synergistic induction by Wnt-1 and retinoic acid. , 2001, Cancer research.

[140]  D. Gabrilovich,et al.  Mechanism of Immune Dysfunction in Cancer Mediated by Immature Gr-1+ Myeloid Cells1 , 2001, The Journal of Immunology.

[141]  P. Chambon,et al.  The retinoic acid-metabolizing enzyme, CYP26A1, is essential for normal hindbrain patterning, vertebral identity, and development of posterior structures. , 2001, Genes & development.

[142]  Kristen Jepsen,et al.  Combinatorial Roles of the Nuclear Receptor Corepressor in Transcription and Development , 2000, Cell.

[143]  N. Noy.  Retinoid-binding proteins: mediators of retinoid action. , 2000, The Biochemical journal.

[144]  D. Carbone,et al.  Clinical significance of defective dendritic cell differentiation in cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[145]  C. Glass,et al.  Determinants of coactivator LXXLL motif specificity in nuclear receptor transcriptional activation. , 1998, Genes & development.

[146]  T. Naoe,et al.  Treatment with a new synthetic retinoid, Am80, of acute promyelocytic leukemia relapsed from complete remission induced by all-trans retinoic acid. , 1997, Blood.

[147]  S. Schreiber,et al.  Nuclear Receptor Repression Mediated by a Complex Containing SMRT, mSin3A, and Histone Deacetylase , 1997, Cell.

[148]  M. Donovan,et al.  The cellular retinoic acid binding proteins , 1995, The Journal of Steroid Biochemistry and Molecular Biology.

[149]  K. Umesono,et al.  A direct repeat in the cellular retinol-binding protein type II gene confers differential regulation by RXR and RAR , 1991, Cell.

[150]  K. Umesono,et al.  Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors , 1991, Cell.

[151]  W. Blaner.  Retinol-binding protein: the serum transport protein for vitamin A. , 1989, Endocrine reviews.

[152]  R. Evans,et al.  Identification of a new class of steroid hormone receptors , 1988, Nature.

[153]  Pierre Chambon,et al.  A human retinoic acid receptor which belongs to the family of nuclear receptors , 1987, Nature.

[154]  V. Giguère,et al.  Identification of a receptor for the morphogen retinoic acid , 1987, Nature.

[155]  S. Collins,et al.  Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[156]  F. Dammacco.  Clinical and Experimental Medicine , 2018 .

[157]  N. Isoherranen,et al.  Role of Retinoic Acid-Metabolizing Cytochrome P450s, CYP26, in Inflammation and Cancer. , 2015, Advances in pharmacology.

[158]  Cheng-Ying Wu,et al.  Cellular retinoic acid binding protein I mediates rapid non-canonical activation of ERK1/2 by all-trans retinoic acid. , 2013, Cellular signalling.

[159]  T. Jiang,et al.  Genome-wide DNA methylation profiling identifies ALDH1A3 promoter methylation as a prognostic predictor in G-CIMP- primary glioblastoma. , 2013, Cancer letters.

[160]  W. Blaner,et al.  Hepatic metabolism of retinoids and disease associations. , 2012, Biochimica et biophysica acta.

[161]  W. Agace,et al.  How vitamin A metabolizing dendritic cells are generated in the gut mucosa. , 2012, Trends in immunology.

[162]  P. Sinha,et al.  Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine. , 2010, Cancer research.

[163]  R. Blomhoff,et al.  Retinoic acid receptor signaling levels and antigen dose regulate gut homing receptor expression on CD8+ T cells , 2008, Mucosal Immunology.

[164]  M. Colombo,et al.  The terminology issue for myeloid-derived suppressor cells. , 2007, Cancer research.

[165]  I. Wang,et al.  Vitamin A deficiency in mice causes a systemic expansion of myeloid cells. , 2000, Blood.

[166]  J. Hardcastle,et al.  Colorectal cancer , 1993, Europe Against Cancer European Commission Series for General Practitioners.

[167]  S. Collins,et al.  Terminal differentiation of human promyelocytic leukemic cells in primary culture in response to retinoic acid. , 1981, Blood.